Published in JAMA Psychiatry · View the paper (DOI)
A meta-analysis of nine published randomized trials found that mindfulness-based cognitive therapy (MBCT) was associated with a reduced risk of depressive relapse/recurrence over 60 weeks. The treatment effect appeared to be larger in patients with higher levels of depression symptoms at baseline.
Coverage from 2 institutions
-
Mindfulness-based cognitive therapy linked to reduced depressive relapse risk
-
Article 1
JAMA Network · Apr 27, 2016 · first to report
-
Article 2
University of Oxford · Apr 27, 2016